<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04527848</url>
  </required_header>
  <id_info>
    <org_study_id>12347319.9.0000.8807</org_study_id>
    <nct_id>NCT04527848</nct_id>
  </id_info>
  <brief_title>Comparison of Two Intraocular Gas Injection Techniques in Macula Hole Surgery</brief_title>
  <official_title>Comparison of Two Intraocular Gas Injection Techniques in Macula Hole Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal de Pernambuco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade Federal de Pernambuco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To undertake a prospective randomized clinical trial of vitrectomy and gas tamponade to treat&#xD;
      macular hole, utilizing a small amount of undiluted C3F8 (perfluoropropane) versus a large&#xD;
      amount of diluted C3F8 versus a small amount of undiluted SF6 (sulfur hexafluoride) versus a&#xD;
      large amount of diluted SF6.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 10, 2016</start_date>
  <completion_date type="Actual">July 31, 2020</completion_date>
  <primary_completion_date type="Actual">July 31, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>The individuals were randomized in a 1: 1: 1: 1 ratio. Block sizes of 4 individuals stratified according to gas type were used (SF6 or C3F8). In each block, two individuals were allocated to each group (0.9-1.0 mL of 100% gas or 15-20 mL of 20% gas).</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Gas duration</measure>
    <time_frame>up to 60 days</time_frame>
    <description>duration of intraocular gas</description>
  </primary_outcome>
  <primary_outcome>
    <measure>macula hole closure</measure>
    <time_frame>26 weeks</time_frame>
    <description>closure of the macular hole after the primary surgical procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>visual acuity</measure>
    <time_frame>preoperative, 26 weeks</time_frame>
    <description>corrected distance visual acuity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intraocular pressure</measure>
    <time_frame>preoperative, 1 day, 26 weeks</time_frame>
    <description>intraocular pressure</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Macular Holes</condition>
  <arm_group>
    <arm_group_label>small amount of undiluted C3F8</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>large amount of diluted C3f8</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>small amount of undiluted SF6</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>large amount of diluted SF6</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>small amount of undiluted C3F8</intervention_name>
    <description>vitrectomy followed by peeling of the internal limiting membrane and, after that, intraocular gas injection</description>
    <arm_group_label>large amount of diluted C3f8</arm_group_label>
    <arm_group_label>large amount of diluted SF6</arm_group_label>
    <arm_group_label>small amount of undiluted C3F8</arm_group_label>
    <arm_group_label>small amount of undiluted SF6</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  pseudophakia&#xD;
&#xD;
          -  without previous vitreoretinal surgery&#xD;
&#xD;
          -  diagnosed with a full-thickness macula hole on the optical coherence tomography exam.&#xD;
&#xD;
          -  duration of symptoms less than 6 months&#xD;
&#xD;
          -  inform consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ocular trauma&#xD;
&#xD;
          -  allergy to any of the products used in the study,&#xD;
&#xD;
          -  need to travel by plane in the first 60 postoperative days&#xD;
&#xD;
          -  myopia over 6 diopters or axial diameter over 26 mm&#xD;
&#xD;
          -  retinal dystrophies&#xD;
&#xD;
          -  retinal detachment&#xD;
&#xD;
          -  abnormal eye shape&#xD;
&#xD;
          -  glaucoma&#xD;
&#xD;
          -  diabetic retinopathy or other eye comorbidities.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rodrigo PC Lira, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UFPE</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UFPE Ophthalmology</name>
      <address>
        <city>Recife</city>
        <state>PE</state>
        <zip>50740600</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>August 23, 2020</study_first_submitted>
  <study_first_submitted_qc>August 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 27, 2020</study_first_posted>
  <last_update_submitted>December 7, 2020</last_update_submitted>
  <last_update_submitted_qc>December 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal de Pernambuco</investigator_affiliation>
    <investigator_full_name>Rodrigo Pessoa Cavalcanti Lira</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>macular holes</keyword>
  <keyword>Injections, Intra-Ocular</keyword>
  <keyword>gases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Perforations</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

